These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3254829)

  • 1. Pinacidil: potassium channel openers in the treatment of hypertension. Proceedings of a symposium. Copenhagen, 10-11 March, 1988.
    Drugs; 1988; 36 Suppl 7():1-98. PubMed ID: 3254829
    [No Abstract]   [Full Text] [Related]  

  • 2. Introductory remarks: symposium on pinacidil: potassium channel openers in the treatment of hypertension.
    Weston AH
    Drugs; 1988; 36 Suppl 7():1-3. PubMed ID: 3254828
    [No Abstract]   [Full Text] [Related]  

  • 3. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Friedel HA; Brogden RN
    Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of pinacidil and prazosin on blood pressure, weight, plasma volume, the renin-angiotensin-aldosterone system, and the renal kallikrein-kinin system in patients with essential hypertension.
    Solomon RJ; Weinberg MS
    J Clin Hypertens; 1987 Dec; 3(4):589-95. PubMed ID: 3330989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
    Goldberg MR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of pinacidil and nifedipine in the treatment of arterial hypertension.
    Jürgensen HJ
    Drugs; 1988; 36 Suppl 7():67-9. PubMed ID: 3076138
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension.
    Koliopoulos K; Papadoyannis DE; Karatzas NB
    Eur J Clin Pharmacol; 1984; 27(3):287-9. PubMed ID: 6510455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.
    Goldberg MR; Rockhold FW; Thompson WL; DeSante KA
    J Clin Pharmacol; 1989 Jan; 29(1):33-40. PubMed ID: 2708546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
    Sterndorff B; Johansen P
    Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
    [No Abstract]   [Full Text] [Related]  

  • 11. A symposium: Guanfacine--a new choice in centrally acting antihypertensive agents. October 5-6, 1984, Scottsdale, Arizona.
    Am J Cardiol; 1986 Mar; 57(9):1E-61E. PubMed ID: 3513524
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary evaluation of pinacidil in hypertension.
    Ramsay LE; Freestone S
    Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinacidil monotherapy for hypertension.
    Ward JW
    Br J Clin Pharmacol; 1984 Aug; 18(2):223-5. PubMed ID: 6487460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension with bethanidine (esbatal).
    Yeoh OS; Chew BK
    Singapore Med J; 1968 Dec; 9(4):266-70. PubMed ID: 5728865
    [No Abstract]   [Full Text] [Related]  

  • 15. Guanfacine (Estulic) in the treatment of hypertension.
    Cor Vasa; 1987; 29(4 Suppl 1):1-52. PubMed ID: 3315446
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):381-6. PubMed ID: 4029244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment in mild hypertension, its problems and future trends.
    Widimský J
    Cor Vasa; 1987; 29(4 Suppl 1):1-10. PubMed ID: 3315445
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclazenin in the treatment of arterial hypertension].
    Salvetti A; Romanelli R
    Policlinico Prat; 1969 Jun; 76(24):777-82. PubMed ID: 5404717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.